180 related articles for article (PubMed ID: 10597264)
1. Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice.
Murphy KL; Kittrell FS; Gay JP; Jäger R; Medina D; Rosen JM
Oncogene; 1999 Nov; 18(47):6597-604. PubMed ID: 10597264
[TBL] [Abstract][Full Text] [Related]
2. A transgenic mouse model for mammary carcinogenesis.
Li B; Murphy KL; Laucirica R; Kittrell F; Medina D; Rosen JM
Oncogene; 1998 Feb; 16(8):997-1007. PubMed ID: 9519874
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice.
Jäger R; Herzer U; Schenkel J; Weiher H
Oncogene; 1997 Oct; 15(15):1787-95. PubMed ID: 9362445
[TBL] [Abstract][Full Text] [Related]
4. Expression of a viral oncoprotein during mammary gland development alters cell fate and function: induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells.
Li M; Hu J; Heermeier K; Hennighausen L; Furth PA
Cell Growth Differ; 1996 Jan; 7(1):3-11. PubMed ID: 8788028
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
Böttinger EP; Jakubczak JL; Haines DC; Bagnall K; Wakefield LM
Cancer Res; 1997 Dec; 57(24):5564-70. PubMed ID: 9407968
[TBL] [Abstract][Full Text] [Related]
6. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.
Li M; Lewis B; Capuco AV; Laucirica R; Furth PA
Oncogene; 2000 Feb; 19(8):1010-9. PubMed ID: 10713684
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
[TBL] [Abstract][Full Text] [Related]
8. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
[TBL] [Abstract][Full Text] [Related]
9. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.
Witty JP; Lempka T; Coffey RJ; Matrisian LM
Cancer Res; 1995 Apr; 55(7):1401-6. PubMed ID: 7882342
[TBL] [Abstract][Full Text] [Related]
10. Increased susceptibility to carcinogen-induced mammary tumors in MMTV-Cdc25B transgenic mice.
Yao Y; Slosberg ED; Wang L; Hibshoosh H; Zhang YJ; Xing WQ; Santella RM; Weinstein IB
Oncogene; 1999 Sep; 18(37):5159-66. PubMed ID: 10498865
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
Vail ME; Pierce RH; Fausto N
Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice.
Krepulat F; Löhler J; Heinlein C; Hermannstädter A; Tolstonog GV; Deppert W
Oncogene; 2005 Jul; 24(29):4645-59. PubMed ID: 15870706
[TBL] [Abstract][Full Text] [Related]
13. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP
Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086
[TBL] [Abstract][Full Text] [Related]
14. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.
Rossiter H; Beissert S; Mayer C; Schön MP; Wienrich BG; Tschachler E; Kupper TS
Cancer Res; 2001 May; 61(9):3619-26. PubMed ID: 11325830
[TBL] [Abstract][Full Text] [Related]
15. Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis.
Hadsell DL; Murphy KL; Bonnette SG; Reece N; Laucirica R; Rosen JM
Oncogene; 2000 Feb; 19(7):889-98. PubMed ID: 10702797
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
[TBL] [Abstract][Full Text] [Related]
17. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O
Oncogene; 2000 Dec; 19(52):6007-14. PubMed ID: 11146552
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice.
Kirma N; Gill K; Mandava U; Tekmal RR
Cancer Res; 2001 Mar; 61(5):1910-8. PubMed ID: 11280746
[TBL] [Abstract][Full Text] [Related]
19. HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53.
Klein A; Guhl E; Tzeng YJ; Fuhrhop J; Levrero M; Graessmann M; Graessmann A
Oncogene; 2003 May; 22(19):2910-9. PubMed ID: 12771941
[TBL] [Abstract][Full Text] [Related]
20. Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice.
Zhang M; Shi Y; Magit D; Furth PA; Sager R
Oncogene; 2000 Dec; 19(52):6053-8. PubMed ID: 11146557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
